Growth Metrics

Marimed (MRMD) Cash from Investing Activities (2016 - 2025)

Marimed (MRMD) has disclosed Cash from Investing Activities for 14 consecutive years, with -$197000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 83.58% to -$197000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2025, up 91.95% year-over-year, with the annual reading at -$1.4 million for FY2025, 91.95% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$197000.0 at Marimed, up from -$514000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$115000.0 in Q1 2025, with the low at -$16.7 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$4.4 million, with a median of -$3.7 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities plummeted 501.39% in 2021, then soared 97.3% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$3.2 million in 2021, then grew by 21.93% to -$2.5 million in 2022, then crashed by 152.61% to -$6.3 million in 2023, then skyrocketed by 81.1% to -$1.2 million in 2024, then surged by 83.58% to -$197000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$197000.0, -$514000.0, and -$554000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.